BNT321, a novel monoclonal antibody targeting sialyl Lewis A: Phase 1 monotherapy and combination with mFOLFIRINOX in patients with advanced CA19-9 expressing cancers Meeting Abstract
| Authors: | O'Reilly, E. M.; Bauer, T. M.; Borazanci, E. H.; Pelster, M.; Varghese, A. M.; Park, W.; Patel, M. R.; Jameson, G. S.; Larsen, M.; Chin, K.; Melink, T. J.; Gutheil, J.; Cosgrove, E. O.; Balogh, K. N.; Maiwald, T.; DeMario, M.; Celik, I.; Türeci, Ö; Sahin, U.; Wang, J. S. |
| Abstract Title: | BNT321, a novel monoclonal antibody targeting sialyl Lewis A: Phase 1 monotherapy and combination with mFOLFIRINOX in patients with advanced CA19-9 expressing cancers |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500643 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.654 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 654 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
